Acesso livre
Acesso livre

Hematologia

Revisão | Tromboembolismo venoso associado a câncer.

22 Fev, 2022 | 14:37h

Cancer-associated venous thromboembolism – Nature Reviews Disease Primers (se o acesso a este link for pago, tente este)

Infográfico: Cancer-associated venous thromboembolism – Nature Reviews Disease Primers (se o acesso a este link for pago, tente este)

Conteúdos relacionados:

NCCN Guideline: Cancer-Associated Venous Thromboembolic Disease.

ASH 2021 guidelines for prevention and treatment of venous thromboembolism in patients with cancer

Review: venous and arterial thromboembolism in patients with cancer.

Systematic Review: Does testing for cancer in people with unprovoked blood clots in the legs and lungs reduce cancer- and blood clot-related death and illness?

M-A: Extended thromboprophylaxis after hospital discharge for medically ill patients with cancer – Extended thromboprophylaxis is not associated with a reduced rate of venous thromboembolic events and is associated with increased risk of hemorrhage

Systematic review: Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy

Isatuximabe com pomalidomida e baixa dose de dexametasona vs. pomalidomida e baixa dose de dexametasona em pacientes com mieloma múltiplo refratário e recidivante (ICARIA-MM): análise do seguimento de um estudo randomizado de fase 3.

22 Fev, 2022 | 14:15h

Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study – The Lancet Oncology (link para o resumo – $ para o texto completo)

Revisão | Resposta a doses adicionais de vacinas contra COVID-19 em pessoas imunocomprometidas.

17 Fev, 2022 | 14:43h

Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review – The Lancet Global Health

 

Comentário no Twitter

 

Estudo prospectivo de diagnóstico e tratamento | Diagnóstico de trombose venosa profunda com D-dímero ajustado para probabilidade clínica.

17 Fev, 2022 | 14:23h

Diagnosis of deep vein thrombosis with D-dimer adjusted to clinical probability: prospective diagnostic management study – The BMJ

Uma ampla coorte de pacientes com síndrome nefrótica mostrou que o risco de tromboembolismo arterial (HR = 3,11), tromboembolismo venoso (HR = 7,11) e sangramento (HR = 4,02) foi bastante aumentado após ajuste dos elementos confundidores.

15 Fev, 2022 | 11:27h

Risk of arterial thromboembolism, venous thromboembolism, and bleeding in patients with nephrotic syndrome: A population-based cohort study – American Journal of Medicine (link para o resumo – $ para o texto completo)

Revisão | Tratamento do tromboembolismo venoso na gestação.

14 Fev, 2022 | 15:44h

Management of venous thromboembolism in pregnancy – Thrombosis Research

Conteúdos relacionados:

Management of high-risk pulmonary embolism in pregnancy.

Study: Diagnosis of Pulmonary Embolism During Pregnancy

Imaging is the only way to diagnose blood clots in pregnancy

Prevention and Treatment of Pregnancy-Associated Venous Thromboembolism: Critical Appraisal of International Guidelines

Terapia genética com betibeglogene autotemcel para betatalassemia não-beta-0/beta-0.

14 Fev, 2022 | 15:39h

Betibeglogene Autotemcel Gene Therapy for Non–β0/β0 Genotype β-Thalassemia – New England Journal of Medicine (link para o resumo – $ para o texto completo)

 

Comentário no Twitter

 

Diretriz atualizada da IDSA para Covid-19 agora apoia o uso de plasma convalescente em pacientes ambulatoriais com COVID-19 leve a moderada sob alto risco de progressão para doença grave.

10 Fev, 2022 | 13:18h

IDSA Guidelines on the Treatment and Management of Patients with COVID-19 – Infectious Diseases Society of America

Conteúdo relacionado: [Preprint] RCT: In symptomatic adults above 18 years positive for SARS-CoV-2, early outpatient treatment with high-titer convalescent plasma significantly reduced hospitalizations.

 

Comentário no Twitter

 

Diretrizes de consenso da Australásia para uso de agentes antifúngicos em hemato-oncologia.

10 Fev, 2022 | 13:05h

Introduction to the updated Australasian consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting, 2021

Consensus guidelines for antifungal stewardship, surveillance and infection prevention, 2021

Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant recipients, 2021

Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2021

Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021

Consensus guidelines for the diagnosis and management of cryptococcosis and rare yeast infections in the haematology/oncology setting, 2021

Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021

Consensus guidelines for the diagnosis and management of invasive fungal disease due to moulds other than Aspergillus in the haematology/oncology setting, 2021

Consensus guidelines for improving patients’ understanding of invasive fungal disease and related risk prevention in the haematology/oncology setting, 2021

Consenso de especialistas | Algoritmo de tratamento da trombose associada a câncer.

10 Fev, 2022 | 13:02h

Treatment Algorithm in Cancer-Associated Thrombosis: Updated Canadian Expert Consensus – Current Oncology

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.